IGC Pharma, Inc.

IGC Pharma, Inc.verified

IGC

Price:

$0.28

Market Cap:

$28.03M

IGC Pharma, Inc. operates as a pharmaceutical firm, currently in the clinical development phase, dedicated to pioneering novel treatments for Alzheimer's, a debilitating condition. The company's pipeline includes two experimental drug candidates aimed at this disease: IGC-AD1, which is presently undergoing a Phase 2 clinical study for addressing agitation associated with Alzheimer's-related dementia, and TGR-63, which is still in its preclinical stage. Beyond its therapeutic development efforts, IGC Pharma also explores the application of artificial intelligence (AI) to advance Alzheimer's research. Established on April 29, 2005, by Ram Mukunda, the company maintains its principal office in ...[Read more]

Industry

Biotechnology

IPO Date

2006-05-24

Stock Exchange

AMEX

Ticker

IGC

The Enterprise Value as of June 2026 (TTM) for IGC Pharma, Inc. (IGC) is 27.82M

According to IGC Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 27.82M. This represents a change of -1.24% compared to the average of 28.17M of the last 4 quarters.

IGC Pharma, Inc. (IGC) Historical Enterprise Value (quarterly & annually)

How has IGC Enterprise Value performed in the past?

The mean historical Enterprise Value of IGC Pharma, Inc. over the last ten years is 27.70M. The current 27.82M Enterprise Value has changed 9.94% with respect to the historical average. Over the past ten years (40 quarters), IGC's Enterprise Value was at its highest in in the September 2018 quarter at 278.35M. The Enterprise Value was at its lowest in in the December 2018 quarter at -15949320.00.

Quarterly (TTM)
Annual

Average

27.70M

Median

23.21M

Minimum

12.72M

Maximum

61.64M

IGC Pharma, Inc. (IGC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of IGC Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 384.75%

Maximum Annual Enterprise Value = 61.64M

Minimum Annual Increase = -72.32%

Minimum Annual Enterprise Value = 12.72M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202624.79M14.55%
202521.64M-20.32%
202427.16M79.44%
202315.13M-59.74%
202237.59M-39.02%
202161.64M384.75%
202012.72M-72.32%
201945.93M183.30%
201816.21M14.46%
201714.17M43.83%

IGC Pharma, Inc. (IGC) Average Enterprise Value

How has IGC Enterprise Value performed in the past?

The current Enterprise Value of IGC Pharma, Inc. (IGC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

24.53M

5-year avg

25.26M

10-year avg

27.70M

IGC Pharma, Inc. (IGC) Enterprise Value vs. Peers

How is IGC’s Enterprise Value compared to its peers?

IGC Pharma, Inc.’s Enterprise Value is less than Nutriband Inc. (37.41M), less than AN2 Therapeutics, Inc. (76.40M), less than Boundless Bio, Inc. (62.48M), greater than Plus Therapeutics, Inc. (9.83M), less than Q32 Bio Inc. (121.73M), less than Pluri Inc. (50.39M), greater than Iterum Therapeutics plc (24.60M), greater than SAB Biotherapeutics, Inc. (17.48M), greater than NextCure, Inc. (-4681544.00), greater than Intensity Therapeutics, Inc. (-3315836.00),

Build a custom stock screener for IGC Pharma, Inc. (IGC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like IGC Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

IGC Pharma, Inc. (IGC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like IGC Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is IGC Pharma, Inc.'s Enterprise Value?

What is the highest Enterprise Value for IGC Pharma, Inc. (IGC)?

What is the 3-year average Enterprise Value for IGC Pharma, Inc. (IGC)?

What is the 5-year average Enterprise Value for IGC Pharma, Inc. (IGC)?

How does the current Enterprise Value for IGC Pharma, Inc. (IGC) compare to its historical average?